Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells

British Journal of Cancer

Volumn 81, Issue 7, 1999, Pages 1174-1181

  Dhar, K K ^a,c   Branigan, K ^a   Parkes, J ^b   Howells, R E J ^c   Hand, P ^d   Musgrove, C ^d   Strange, R C ^a   Fryer, A A ^a   Redman, C W E ^c   Hoban, P R ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b STAFFORDSHIRE GENERAL HOSPITAL   (United Kingdom)

^c CITY GENERAL HOSPITAL   (United Kingdom)

^d Central Pathology Laboratory   (United Kingdom)

Author keywords

Amplification; Clinical outcome; Cyclin D1; Cytoplasm: nucleus; Ovarian cancer

Indexed keywords

CYCLIN D1; MONOCLONAL ANTIBODY;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032713427     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690826     Document Type: Article

References (39)

1. Barbieri F, Cagnoli M, Ragni N, Pedulla F, Foglia G and Alama A (1997) Expression of cyclin D1 correlates with malignancy in human ovarian tumours. Br J Cancer 75: 1263-1268
2. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, Scambia G and Neri G (1996) Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2: 175-180
3. Betticher DC, Heighway J, Haselton PS, Altermatt HJ, Ryder WDJ, Cerny T and Thatcher N (1996) Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 73: 294-300
4. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WDJ and Heighway J (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011
5. Bringuier PP, Tamimi YE, Schuuring E and Schalken J (1996) Expression of cyclin D1 and EMS1 in bladder tumours: relationship with chromosome Hq13 amplification. Oncogene 12: 1747-1753
6. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA and Batsakis JG (1994) PRAD 1 (CCND1)/Cyclin D1 oncogene amplification in head and neck squamous cell carcinoma. Cancer 74: 152-158
7. Chang J, Bridgewater J, Gore M, Fischer C, Schofield J, A'Hern R, Ponder B, Jacobs I, McKeage M, Kelland L and Harap K (1994) Non surgical aspects of ovarian cancer. Lancet 343: 335-340
8. Courjal E, Louason G, Speisei P, Katsaros D, Zeillinger R and Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumours. Int J Cancer 69: 247-253
9. de Boer CJ, Loyson S, Kluin PM, Kluin-Nelemans HC, Schruuring E and van Krieken JH (1993) Multiple breakpoints with the bcl-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Res 53: 4148-4152
10. de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM and van Krieken JH (1995) Cyclin D1 protein analysis in the diagnosis of matel cell lymphoma. Blood 86: 2715-2723
11. Dhar KK, Branigan K, Hand P, Howells R, Redman C, Strange R, Heighway J and Hoban P (1997) Analysis of Cyclin D1 amplification and overexpression in ovarian cancer. Acta Obstet Gynaecol Scand 76: 19
12. Diehl JA and Sherr CJ (1997) A dominant-negative mutant prevents nuclear import of cyclin dependent kinase 4 (CDK4) and its phosphorylation by CDK activating kinase. Mol Cell Biol 17: 7362-7364
13. Dulie V, Drullinger LF, Lees E, Reed SI and Stein GH (1993) Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci USA 90: 11034-11038
14. Foulkes WD, Campbell IG, Stamp G and Trowsdale J (1993) Loss of heterozygosity and amplification on chromosome Hq in human ovarian cancer. Br J Cancer 67: 268-273
15. Gabra H, Watson JEV, Taylor KJ, Mackay J, Leonard RC, Steel CM, Porteous DJ and Smyth JF (1996) Definition and refinement of loss of heterozygosity at Hq23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56: 950-954
16. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N and Beger H (1997) Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 57: 1634-1637
17. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817
18. Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G and Barnes D (1996) Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69: 92-99
19. Howells REJ, Redman CWE, Dhar KK, Sarhanis P, Musgrove C, Jones PW, Alldersea J, Fryer AA, Hoban P and Strange RC (1998) Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin Cancer Res 4: 2439-2445
20. Hung W-C, Chai C-Y, Huang J-S and Chuang L-Y (1996) Expression of cyclin D1 and c-Ki-ras gene in human epithelial ovarian tumours. Hum Pathol 27: 1324-1328
21. Kotelnikov VM, Coon JS, Mundle S, Kelanie S, LaFollette S, Taylor IVS, Hutchinson J, Panje W, Caldarelli DD and Preisler HD (1997) Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin Cancer Res 3: 95-101
22. Kranenburg O, van der Eb AJ and Zantema A (1996) Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 15: 46-54
23. Kurzrock R, Ku S and Talpaz M (1995) Abnormalities in the PRAD1 (Cyclin D1/ BCL-1) oncogene are frequent in cervical and vulval squamous cell carcinoma cell lines. Cancer 75: 584-590
24. Kwon TK, Buchholz MA, Gabrielson EW and Nordin AA (1995) A novel cytoplasmic substrate for cdk4 and cdk6 in normal and malignant epithelial derived cells. Oncogene 11: 2077-2083
25. La Baer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattacy A and Harlow E (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev 11: 847-862
26. Lukas J, Bartkova J, Welcker M, Peterson O, Peters G, Strauss M and Bartek J (1995) Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10: 2125-2134
27. Lucibello FC, Sewing A, Brusselbach S, Burger C and Muller R (1993) Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 105: 123-133
28. Masciullo V, Scambia G, Marone M, Giannitelli C, Ferrandina G, Bellacosa A, Bendetti Panici P and Mancus OS (1997) Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Int J Cancer 74: 390-395
29. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978
30. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM and Arnold A (1991) A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature 350: 512-515
31. Musgrove EA, Lee CS, Buckley MF and Sutherland RL (1994) Cyclin D1 induction in breast cancer cells shorten G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 91: 8022-8026
32. Nakamura S, Seto M, Banno S, Suzuki S, Koshikawa T, Kitoh K, Kagami Y, Ogura M, Yatabe Y, Kojima M, Motoori T, Takabashi T, Ueda R and Suchi T (1994) Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantel cell lymphoma Jpn J Cancer Res 85: 1270-1279
33. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M and Ishizaki K (1994) Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54: 3107-3110
34. Palmero I and Peters G (1996) Perturbation of cell cycle regulators in human cancer. Cancer Surveys 27: 351-367
35. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF and Sherr CJ (1993) Overexpression of mouse D type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559-1571
36. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor NY, USA
37. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamanda H, Hara M and Saito I (1998) Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16: 1701-1712
38. Sherr CJ (1996) Cancer cell cycles. Science 274: 1672-1677
39. Worsley S, Ponder BAJ and Davies BR (1997) Overexpression of cyclin D1 in epithelial ovarian cancers. Gynecol Oncol 64: 189-195